HNF4A and cancer: Further study found that BBR could reduce the expression of HNF4α, WNT5A, and cytoplasmic β-catenin in cancer tissues, and the regulation of HNF4α-Wnt5a is a crosstalk between AMPK metabolic pathway and WNT signaling pathway.